Join Venture Café Phoenix for its weekly Thursday gathering. This week’s topic will be: Foundations – Health and Nutrition Part 2.
Please join us as a panel of Life-Science entrepreneurs discuss their experiences writing successful SBIR and STTR grants.
Michael D. Dake, MD, senior vice president for the University of Arizona Health Sciences, will introduce a new Phoenix-based research center that will accelerate the development and availability of personalized cell and gene-based therapies, and serve as the hub of a new innovation district at the downtown Phoenix Bioscience Core.
Join Venture Café Phoenix for its weekly Thursday gathering. This week’s topic will be: A.I. & WearTech, featuring sister city Prague, Czech Republic
This hybrid event will feature several sessions detailing the COVID-19 pandemic and how it affected various health disciplines.
Join Venture Café Phoenix for its weekly Thursday gathering. This week’s topic will be: Foundations – Mental Health
Join Venture Café Phoenix for its weekly Thursday gathering. This week’s topic will be: Blockchain, NFT & Crypto
Learn more and register.
Join Venture Café Phoenix for its weekly Thursday gathering. This week’s topic will be: Fashion and Arts
Learn more and register.
Featured Speaker: Tassos, CEO, MyoKardia who will share his journey from conception to acquisition.
Myth or Fact? “Straight” people don’t have to worry about HIV infection.
This is a myth. Misinformation about LGBTQ+ health issues contributes to biases against the community, creates confusion over important health questions, and can even prevent some from seeking health care when needed. The more we know about our health, the more empowered we can become to make informed health decisions that affect us daily. Join us as we confront, dispel, and correct common LGBTQ+ health myths and discuss what everyone can do to help eradicate barriers to inclusive medical treatment and ensure representation in health research for all.
Join Venture Café Phoenix for its weekly Thursday gathering. This week’s topic will be: Electric Vehicles in Phoenix
Learn more and register here.
Please join us as Tassos discusses his journey from conception to acquisition. MyoKardia was acquired in 2020 by Bristol Myers Squibb for $13.1 Billion in Cash.
